BioCentury
ARTICLE | Clinical News

Forbes Medi-Tech begins Phase II

April 4, 2000 7:00 AM UTC

FMTI began a U.S. Phase II trial of its CardioRex plant sterol from paper pulp to reduce LDL cholesterol. ...